SCHEMBL7873271

SCHEMBL7873271

CNC(N)=NC(=O)c1cc2ccc(Oc3ccccn3)cc2[nH]1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BTK Q06187 2/20 0.44
SCN7A Q01118 4/20 0.41
KCNH2 Q12809 4/20 0.41
PDGFRB P09619 1/20 0.40
PDGFRA P16234 1/20 0.40
FLT3 P36888 1/20 0.40
DHODH Q02127 1/20 0.39
PTGS2 P35354 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
HTR2C P28335 1/20 0.37
SYK P43405 1/20 0.37
PDE10A Q9Y233 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
XDH P47989 1/20 0.36
SCN5A Q14524 1/20 0.36
SCN2A Q99250 1/20 0.36
SCN8A Q9UQD0 1/20 0.36
EGLN2 Q96KS0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7884822 0.88 FLT3 (0.35) BTKPDGFRBPDGFRAFLT3MEN1
SCHEMBL7882069 0.85 XDH (0.51) BTKPDGFRBPDGFRAFLT3MEN1
SCHEMBL7881902 0.85 LOXL2 (0.46)
SCHEMBL7877766 0.84 DHODH (0.36) BTKSCN7AKCNH2DHODHPTGS2
SCHEMBL7885071 0.83 XDH (0.39) PDGFRBPDGFRAFLT3MEN1KMT2A
SCHEMBL7877951 0.83 HRH4 (0.37) PDGFRBPDGFRAFLT3MEN1KMT2A
SCHEMBL7879701 0.83 ROCK2 (0.41) PDGFRBPDGFRAFLT3XDH
SCHEMBL7882156 0.83 RAF1 (0.35) BTKPDGFRBPDGFRAFLT3DHODH
SCHEMBL7884570 0.82 MEN1 (0.38) FLT3MEN1KMT2ASYKNPC1
SCHEMBL7877724 0.82 BTK (0.44) BTKPDGFRBPDGFRAFLT3XDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed